The Recall Desk
CriticalFDA (Drugs)·D-1203-2018·Announced 2018-09-19

FDA Recalls Respitrol Homeopathic Medicine Due to Microbial Contamination

The FDA is recalling Respitrol Homeopathic OTC Medicine because it is contaminated with microorganisms, including Staphylococcus saprophyticus and Burkholderia cepacia.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The source text explicitly identifies the recall as an FDA Class I recall, which mandates a severity score of 5 according to the rubric.

Plain-English summary

The U.S. Food and Drug Administration (FDA) is recalling Respitrol, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle. The product was manufactured for HelloLife, Inc. in Grand Rapids, Michigan. The recall involves 1,869 bottles with Lot RE/030717E and an expiration date of 7/2019.

The recall was initiated because the product is contaminated with microorganisms, specifically Staphylococcus saprophyticus and Burkholderia cepacia. This is classified as an FDA Class I recall, which indicates a reasonable probability that use of the product will cause serious adverse health consequences or death.

The product was distributed nationwide in the United States and in numerous international locations, including Canada, the United Kingdom, and various countries in Europe, Asia, and South America. Consumers should stop using the product and contact their healthcare provider if they have any concerns.

The recalled product

Product
Respitrol, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512. NDC: 49726-003-02
Manufacturer
Hellolife
Affected units
1,869

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot: RE/030717E
  • exp 7/2019

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 4 recalled by Hellolife under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →